Riferimento farmaci
Cangrelor
Cangrelor is a medicine in the class cardiovascular. It is used for coronary artery stent thrombosis.
- Classe del farmaco: Cardiovascular
- Indicato per: coronary artery stent thrombosis
Ultimo aggiornamento Fonti: US FDA label
Per operatori sanitari — solo a scopo di riferimento. Questa pagina è una sintesi breve, non è un parere medico e non sostituisce il RCP ufficiale né il giudizio clinico. Verificare sempre prima di prescrivere o dispensare.
Il contenuto clinico di questa pagina è disponibile solo in inglese.
In breve
- Classe del farmaco
- Cardiovascular
- Forme farmaceutiche comuni
- iniezione
- Dosaggi comuni
- 50 mg
- Interazioni note
- 3 (Maggiore: 2 · Moderata: 1)
- Nomi commerciali
- 2
- Paesi e mercati
- 2
Per cosa si usa
Come agisce
Direct P2Y12 platelet receptor inhibitor that blocks ADP-induced platelet activation and aggregation; binds selectively and reversibly to the P2Y12 receptor.
Dose abituale nell'adulto (sintesi del foglio illustrativo)
Adjunct to PCI: 30 mcg/kg IV bolus before PCI, followed immediately by 4 mcg/kg/min IV infusion for at least 2 hours or the duration of PCI, whichever is longer.
Gravidanza e allattamento
- Gravidanza
- Unknown No human data. Animal studies showed no malformations, but fetal growth retardation and increased abortion/intrauterine losses occurred at higher doses. May increase maternal bleeding during labor and delivery.
- Allattamento
- Unknown No data on presence in milk; exposure in the breastfed infant is expected to be very low due to short half-life.
Effetti indesiderati segnalati
- Bleeding
- Dyspnea
- Hypersensitivity reactions (anaphylaxis, bronchospasm, angioedema, stridor)
- Worsening renal function in severe renal impairment
Controindicazioni
- Significant active bleeding.
- Known hypersensitivity (e.g., anaphylaxis) to cangrelor or any component of the product.
Chi deve prestare attenzione
- Bleeding risk: P2Y12 inhibitors including cangrelor increase bleeding risk; bleeding events of all severities were more common than with clopidogrel. No antiplatelet effect after an hour once discontinued.
- Neuraxial blockade is not advised during use because of potential spinal hematoma risk; discontinue 1 hour before labor, delivery, or neuraxial blockade when possible.
Informare il farmacista o il medico di gravidanza o allattamento, malattie renali o epatiche, allergie e di ogni altro farmaco o integratore assunto.
Interazioni principali (3)
- Cangrelor + Clopidogrel Major
- Cangrelor + Prasugrel Major
- Cangrelor + Warfarin Moderate
Per gli utenti Pro+
Sblocca la pagina completa
Crei un account e avvii una prova di Pro+ per aprire la monografia completa di Cangrelor: dosi, gravidanza e allattamento, effetti indesiderati, avvertenze e tutte le interazioni.
- Dosing by age, kidney and liver function, and further dose lines
- Renal and hepatic dose adjustments
- Dosing in older adults
- How to give it
- Pharmacokinetics
- IV preparation and dilution
Provi Pro+ gratis per 14 giorni sul web. Nessuna carta.
Altri farmaci della stessa classe
Domande frequenti
What is Cangrelor used for?
Cangrelor is a medicine in the class cardiovascular. It is used for Coronary artery stent thrombosis, Myocardial infarction.
What side effects have been reported with Cangrelor?
Bleeding, Dyspnea, Hypersensitivity reactions (anaphylaxis, bronchospasm, angioedema, stridor), Worsening renal function in severe renal impairment.
Can Cangrelor be taken in pregnancy or while breastfeeding?
Pregnancy: Unknown. No human data. Animal studies showed no malformations, but fetal growth retardation and increased abortion/intrauterine losses occurred at higher doses. May increase maternal bleeding during labor and delivery. Breastfeeding: Unknown. No data on presence in milk; exposure in the breastfed infant is expected to be very low due to short half-life.
What does Cangrelor interact with?
MediHelp lists 3 known interactions for Cangrelor. Major: 2 · Moderate: 1. The most serious include Clopidogrel, Prasugrel, Warfarin.
Monografie complete, posologie e verifica delle interazioni nell'app MediHelp
Apra il riferimento completo, verifichi le interazioni tra più farmaci e usi gli strumenti di posologia nell'app MediHelp.
